The current valuation score of Scienture Holdings Inc is 8.85, ranking 62 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.15, which is -1701.97% below the recent high of 2.44 and -4260.84% above the recent low of -6.64.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.